2024 U.S.-Booked Air Volume: $35.8 million
Primary U.S. Air Suppliers: America, SAS, United
Primary U.S. Hotel Suppliers: Hilton, Marriott, Radisson
Primary U.S. Car Rental Suppliers: Enterprise, Europcar
Primary U.S. Online Booking Tool: SAP Concur
Primary U.S. Payment Supplier: BMO Diners Card
Primary U.S. Expense Supplier: SAP Concur
Global Travel Risk Management Supplier: ISOS
Consolidated U.S. TMC: Amex GBT
Global pharmaceutical company Novo Nordisk spent $35.8 million on U.S.-booked air volume in 2024. That figure was up 41 percent from $25.4 million in 2023, according to the company, which had global T&E spending of $130 million.
Global revenue and employee numbers have experienced similar growth trajectories, with revenue up 24 percent to $41.9 billion in 2024 and employee count as of the end of 2024 numbering nearly 77,300. That’s up 20 percent from the prior year. However, the company in September 2025 announced plans to cut 9,000 jobs, with more than half of those to be made in Denmark.
In 2024 the company began a process to migrate from a broad travel-approval process to requiring approvals only for exceptions in 2025. The company also has sharpened its focus on traveler satisfaction, sustainability initiatives and leveraging technology whenever practical.
The company fully returned to the office in 2024 and also saw business travel spending return to pre-pandemic levels last year.
Novo Nordisk reported 188,000 metric tons of CO2 equivalent in Scope 3 business travel emissions in 2024. Overall Scope 3 emissions increased 24 percent last year due to the company’s “rapid” growth, but it plans to reduce that volume by 33 percent by 2033.